OpenEvidence
AI research agent for verified clinicians (DeepConsult) that cross-references peer-reviewed medical literature to produce PhD-level evidence synthesis.
Delv Safety Grade: B
Score 72/100 · assessed 2026-04-18
OpenEvidence is a clinical research agent built by a healthcare-focused startup, not a major vendor. The company appears legitimate with a clear medical focus and clinician verification process, but lacks the institutional backing of established healthcare tech firms. The agent operates as a web/mobile service with relatively scoped permissions: it reads medical literature databases and synthesises evidence, but doesn't write to patient records or execute code locally. Supply chain is opaque since there's no public repository or package distribution, making independent verification impossible. Transparency is limited—no open source code, thin public documentation about data sources or model architecture. The clinician-only access model and evidence-based approach are positive safety features. No known security incidents, but the closed nature means less community scrutiny than open alternatives.
Green flags
- Clinician verification requirement limits misuse by unqualified users
- Read-only literature access without patient record integration
- Evidence-based approach with direct citations reduces hallucination risk
- No known security incidents or credential leaks
- Scoped to research synthesis without filesystem or shell access
Red flags
- No public repository or source code for independent security review
- Opaque supply chain with no verifiable package distribution
- Limited transparency about underlying models and data sources
- Smaller vendor without established healthcare security track record
- Unclear data retention policies for clinical queries
Permissions requested
Pricing
Platforms
Review
If you're a US clinician who regularly makes evidence-based decisions at the point of care, this is worth installing. Everyone else will find the access restrictions or clinical focus too limiting to justify the workflow change.
Good at
- Cross-references full-text papers, not just abstracts, with direct citations
- Flags contradictory evidence and study quality in a way that's clinically actionable
- Mobile app works offline once reports are cached, useful in hospital dead zones
- Free for verified US clinicians, no subscription upsell
- Outputs are structured enough to paste into clinical notes or teaching slides
Watch out
- Restricted to verified US clinicians, excludes international users and trainees
- Assumes familiarity with epidemiology and study design, dense for generalists
- Occasionally over-weights recent papers at the expense of landmark trials
- No integration with EHR systems, so it's a separate workflow step
- Limited to medical literature, won't help with non-clinical research questions
Use cases
- clinical decision support
- literature review
- point-of-care evidence